Unicycive: FDA to Review Lead Drug Candidate for Hyperphosphatemia
Unicycive, which is seeking an FDA green light for oxylanthanum carbonate to treat hyperphosphatemia in patients with chronic kidney disease who are on dialysis, Monday said the agency set a target ...
SiliconRepublic6h
25 scientists you need to know about
To celebrate Science Week, we’ve put together a bumper list of 25 scientists based in Ireland who are innovating across STEM.
Alembic Pharmaceuticals receives USFDA approval for Diltiazem Hydrochloride ER capsules
Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem ...
pharmaphorum20h
J&J bids to add smouldering myeloma to Darzalex label
The marketing applications with the EMA and FDA are for J&J and partner Genmab's Darzalex Faspro version of the anti-CD38 ...
Pharmabiz2d
AskBio receives US FDA rare paediatric disease & orphan-drug designations for AB-1003 to treat limb-girdle muscular dystrophy type 2I/R9
Research Triangle Park, North Carolina Saturday, November 9, 2024, 13:00 Hrs [IST] ...
Meghan and Harry 'torn' about staying in America - 'This is a hellish situation for them'
EXCLUSIVE: Now that Donald Trump is set to become US President again, a source tells OK! that Prince Harry and Meghan Markle ...
Meghan Markle and Prince Harry 'torn' about remaining in USA amid 'hellish' situation
Meghan Markle and Prince Harry are reportedly 'torn' over their future in the USA as Donald Trump is set to become the 47th ...
The Financial Express3d
USFDA grants tentative approval to Lupin’s generic formulation to treat HIV infection
Global pharma major Lupin Limited on Friday announced that it has received tentative approval from the United States Food and ...
Taiwan News3d
Akeso Published Mechanism of Action for CLDN18.2/CD47 Bispecific Antibody AK132 for the First Time at SITC Annual Meeting
AK132 is a bispecific antibody developed by Akeso, targeting the recombinant humanized Claudin18.2 (CLDN18.2) splice variant 2 and CD47 for the treatment of various cancers, including gastric, ...
Trump May Kick Prince Harry Out Of America Over Drug Boast
If Kevin Roberts, the author of the extreme conservative Project 2025 “blueprint” for a second Trump term, is granted an ...
BioPharma Dive3d
With Trump victorious, biotech industry’s focus turns to his plans for FDA, FTC
The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...
AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designations for AB-1003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9
(AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that AB-1003 (also known as LION-101) has received rare pediatric disease ...